Bespoke Extracts (BSPK) Common Equity (2011 - 2025)

Bespoke Extracts (BSPK) has 15 years of Common Equity data on file, last reported at -$2.6 million in Q3 2025.

• For the quarter ending Q3 2025, Common Equity fell 11.42% year-over-year to -$2.6 million; the trailing twelve-month figure through Sep 2025 stood at -$2.6 million (down 11.42% YoY), and the FY2024 full-year result was -$2.1 million, down 21.3% from the prior year.
• Common Equity declined to -$2.6 million in Q3 2025, from -$2.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $2.0 million in Q1 2022 to a low of -$2.6 million in Q3 2025.
• A 5-year average of -$930336.6 and a median of -$1.3 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity soared 111.92% in 2021 and sank 200.26% in 2023, its largest moves.
• Tracing BSPK's Common Equity over 5 years: stood at -$79724.0 in 2021, then plunged by 743.03% to -$672096.0 in 2022, then tumbled by 156.59% to -$1.7 million in 2023, then retreated by 21.3% to -$2.1 million in 2024, then retreated by 24.07% to -$2.6 million in 2025.
• Business Quant data shows BSPK's Common Equity at -$2.6 million in Q3 2025, -$2.5 million in Q2 2025, and -$2.3 million in Q1 2025.